on GENEURO SA (EPA:GNRO)
GeNeuro's Shareholders Approve All Resolutions at Extraordinary General Meeting
Geneva, Switzerland-based GeNeuro announced that all resolutions proposed at its Extraordinary General Meeting (EGM) on June 30, 2025, were unanimously approved. The meeting saw 69.1% of the company's share capital represented. Shareholders endorsed the re-election of the Board of Directors, with Jesús Martin-Garcia being named Executive Chairman.
Amid restructuring efforts due to prior Phase 2 trial disappointments in Long COVID, GeNeuro is focusing on asset monetization and has undertaken debt restructuring. Despite dismissing all parent company staff by December 2024, Martin-Garcia and Miguel Payró continue part-time in leadership roles.
The company suspended its 2024 financial statement publication, citing uncertainties in the asset monetization process.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all GENEURO SA news